Colinz Laboratories Ltd. reported earnings results for the fourth quarter and full year ended March 31, 2022. For the fourth quarter, the company reported sales was INR 15.82 million compared to INR 16.37 million a year ago. Revenue was INR 16.53 million compared to INR 17.09 million a year ago. Net income was INR 0.701 million compared to INR 0.593 million a year ago. Basic earnings per share from continuing operations was INR 0.15 compared to INR 0.13 a year ago. Diluted earnings per share from continuing operations was INR 0.15 compared to INR 0.13 a year ago.
For the full year, sales was INR 69.74 million compared to INR 61.59 million a year ago. Revenue was INR 71.45 million compared to INR 63.5 million a year ago. Net income was INR 3.39 million compared to INR 2.08 million a year ago. Basic earnings per share from continuing operations was INR 0.74 compared to INR 0.45 a year ago. Diluted earnings per share from continuing operations was INR 0.74 compared to INR 0.45 a year ago.